Our ref.: L/M (67) in ImmD RALS1/6-20/3/C
Dear Ms Anderson,
We refer to your application for access to information of 21 July 2021
relating to sta...
Our ref.: L/M (66) in ImmD RALS1/6-20/3/C
Dear Ms Alam,
We refer to your application for access to information of 20 July 2021
relating to...
Thank you for your response. Would it be possible to provide the information in a CSV or Excel format? The formatting of the statistics has been jumble...
Our ref. : IL/00689623/21
Our Reference: L/M (8) in ImmD ORS/6-5/2 (C) Pt.3
Dear Raquel Amador,
I refer to your application for access to...
Our Reference: L/M (13) in ImmD CIC/6-5/10 (R) Pt.2
Dear Surabhi Chopra,
I refer to your request for access to information on 20 October 2021 and
o...
Our Reference: L/M (540) in ImmD DR/6-5/10/R
Dear Surabhi Chopra,
I refer to your request for access to information on 20 October 2021 and
our int...
Our Reference: L/M (12) in ImmD CIC/6-5/10 (R) Pt.2
Dear Surabhi Chopra,
I refer to your request for access to information on 20 October 2021 and...
Our Reference: L/M (596) in ImmD DR/6-5/10/R
Dear H.Y. FUNG,
I refer to your request for access to information on 10.01.2023 and our
interim replie...
Our ref. : IL/00262457/23, L/M (102) in ImmD RALS1/6-20/3/C
Dear David Lai,
Regarding your email of 14 March 2023 requesting for informatio...
Our reference: RDCD-0000491-23
Dear H. Y. Fung,
I refer to your request for access to information on 30 June 2023. Our
reply is provided as below....
Our Reference: L/M (612) in ImmD DR/6-5/10/R
Dear H.Y. FUNG,
I refer to your request for access to information on 28.08.2023 and our
interim replie...
本處檔號: L/M in ImmD RALOS/6-20/3/C
Dear Ms Li,
Thank you for your email enquiry dated 15 June 2017. Further to our
interim replies dated 24...
Our ref. : L/M in ImmD PRL/6-5/1
Dear Ms Li,
Thank you for your email enquiries of 9 March 2018. Further to our
interim reply on...
Our Reference: L/M (2) in ImmD CIC/6-5/10 (R)
Dear Rachel Li,
I refer to your request for access to information on 11 February 2021 and
our interi...
Our file ref: (13/21) in TS I/AI/1 Pt. 64
Dear Dr. WANG,
We acknowledge receipt of your application dated 19-5-2021 below under the
"Code...
Dear Nina Guiljam,
I refer to your email of 17 November 2022.
In order to enable us to proceed with your request, please clarify...
Dear Nina Guiljam,
I refer to your email of 17 November 2022.
In order to enable us to proceed with your request, please clarify...
Dear Ms. Raquel Amador,
Further to our interim reply of 9.11.2021, a substantive reply to your
request for information is as follows.
2. Purs...
Dear H. Y. Fung,
I refer to your request for access to information on 24 February 2022.
Further to our interim reply of 1 March 2022, our reply is p...
Our reference: RDCD-0000135-23
Dear H. Y. Fung,
I refer to your request for access to information and subsequent
clarification with our Department...
市民nuageamk:
根據《公開資料守則》要求索取資料
申請編號:039/15
謝謝你於2015年8月10日的電郵,跟進有關披露香港公開大學(“公大”)《大
學發展計劃2013-2022》的事宜。
正如本局在早前的回覆中指出,本局並沒擁有公大的《大學發展計...
Dear H. Y. Fung,
I refer to your request for access to information on 14 February 2022.
Further to our interim reply of 21 February 2022, our reply...
Our reference: L/M in ImmD RALOS/6-20/3/C
Dear Ms Li,
Thank you for your email enquiries of 4 October 2017 and another email of
6 Octo...
Our reference: L/M in ImmD RALOS/6-20/3/C
Dear Ms Li,
Thank you for your email enquiries of 4 October 2017 and another email of
6 Octo...
Dear Mr Edmunds,
Thank you for your email of 23 June 2017 requesting for information about
medicine licensing. Our reply is as follows:-
Pharmace...